MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to immunitybio...
-$632,782K
(-388.08%↓ Y/Y)
Net loss
attributable to...
-$15K
(25.00%↑ Y/Y)
Net loss
-$632,797K
(-388.02%↓ Y/Y)
Loss before income
taxes and...
-$632,788K
(-387.13%↓ Y/Y)
Income tax (expense)
benefit
$9K
(103.85%↑ Y/Y)
Product
$44,167K
(167.53%↑ Y/Y)
Product And Service
Other
$39K
(387.50%↑ Y/Y)
Total other expense,
net
-$562,997K
(-759.92%↓ Y/Y)
Loss from operations
-$69,791K
(-8.32%↓ Y/Y)
Interest and investment
income, net
$2,314K
(160.88%↑ Y/Y)
Change in fair value of
derivative liabilities
$1,108K
(-80.14%↓ Y/Y)
Total revenue
$44,206K
(167.64%↑ Y/Y)
Change in fair value of
warrant liabilities
$295,413K
(65840.40%↑ Y/Y)
Change in fair value of
related-party convertible...
-$236,625K
(-455.69%↓ Y/Y)
Interest
expense-Related Party
$14,559K
(-4.92%↓ Y/Y)
Interest expense related
to revenue...
$13,871K
(2.49%↑ Y/Y)
Other expense, net
-$5,917K
(-14331.71%↓ Y/Y)
Total operating costs
and expenses
$113,997K
(40.83%↑ Y/Y)
Interest
expense-Nonrelated Party
$34K
(88.89%↑ Y/Y)
Research and
development-Nonrelated Party
$64,770K
(40.88%↑ Y/Y)
Selling, general and
administrative-Nonrelated Party
$44,461K
(39.04%↑ Y/Y)
Research and
development-Related Party
$3,219K
(42.56%↑ Y/Y)
Selling, general and
administrative-Related Party
$1,309K
(93.35%↑ Y/Y)
Cost of sales
$238K
(310.34%↑ Y/Y)
Back
Back
Income Statement
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
source: myfinsight.com
ImmunityBio, Inc. (IBRX)